In outpatients with mild to moderate COVID-19, low-dose fluvoxamine did not reduce time to sustained recovery
Sign Up to like & getrecommendations! Published in 2023 at "Annals of Internal Medicine"
DOI: 10.7326/j23-0025
Abstract: SOURCE CITATION McCarthy MW, Naggie S, Boulware DR, et al. Effect of fluvoxamine vs placebo on time to sustained recovery in outpatients with mild to moderate COVID-19: a randomized clinical trial. JAMA. 2023;329:296-305. 36633838. read more here.
Keywords: mild moderate; time sustained; moderate covid; outpatients mild ... See more keywords